The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Rational design of new CpG oligonucleotides that combine B cell activation with high IFN‐α induction in plasmacytoid dendritic cells
Open accessAbstract
Two different types of CpG motif‐containing oligonucleotides (CpG ODN) have been described: CpG‐A with high induction of IFN‐α in plasmacytoid dendritic cells; and CpG‐B with little induction of IFN‐α, but potent activation of B cells. In this study, we demonstrate that CpG‐A fail to activate B cells unless plasmacytoid dendritic cells are present. We identified a new set of CpG ODN sequences which induces high levels of IFN‐α in plasmacytoid dendritic cells but remains capable of directly activating B cells. These new CpG ODN (termed CpG‐C) are more potent stimulants of B cells than CpG‐B due to their ability of directly and indirectly (via plasmacytoid dendritic cells) activating B cells. The sequence of CpG‐C combines structural elements of both CpG‐A and CpG‐B. The most potent sequence, M362, contains a 5′‐end ‘TCGTCG‐motif’ and a ‘GTCGTT‐motif’, both of which are present in CpG‐B (ODN 2006); a palindromic sequence characteristic for CpG‐A (ODN 2216); but no poly G motif required for CpG‐A. In conclusion, we defined the first CpG‐containing sequences that potently activate both TLR9‐expressing immune cell subsets in humans, the plasmacytoid dendritic cell and the B cell. CpG‐C may allow for improved therapeutic immuno‐modulation in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,935
Self-citationCella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., & Colonna, M. (1999) · Nature Medicine · doi:10.1038/11360 · Cited by 1,737
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
Bauer, S., Kirschning, C. J., Häcker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., & Lipford, G. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161293498 · Cited by 1,533
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells
Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304
Krug, A., Rothenfusser, S., Hornung, V., Jahrsdörfer, B., Blackwell, S., Ballas, Z. K., Endres, S., Krieg, A. M., & Hartmann, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2154::aid-immu2154>3.0.co;2-u · Cited by 882
Self-citationKrug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., Giese, T., Engelmann, H., Endres, S., Krieg, A. M., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<3026::aid-immu3026>3.0.co;2-h · Cited by 786
Self-citationCpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
Hartmann, G., Weiner, G. J., & Krieg, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9305 · Cited by 626
Self-citationMechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells
Hartmann, G., & Krieg, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.944 · Cited by 605
Self-citationHartmann, G., Weeratna, R. D., Ballas, Z. K., Payette, P., Blackwell, S., Suparto, I., Rasmussen, W. L., Waldschmidt, M., Sajuthi, D., Purcell, R. H., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1617 · Cited by 585
Self-citationHuman Peripheral Blood Cells Differentially Recognize and Respond to Two Distinct CpG Motifs
Verthelyi, D., Ishii, K. J., Gursel, M., Takeshita, F., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2372 · Cited by 529
Jonasch, E., & Haluska, F. G. (2001) · The Oncologist · doi:10.1634/theoncologist.6-1-34 · Cited by 518
Bacterial CpG-DNA Triggers Activation and Maturation of Human CD11c−, CD123+ Dendritic Cells
Bauer, M., Redecke, V., Ellwart, J. W., Scherer, B., Kremer, J.-P., Wagner, H., & Lipford, G. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5000 · Cited by 293
Rönnblom, L., & Alm, G. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.f59 · Cited by 288
Vallin, H., Perers, A., ALM, G. V., & Rönnblom, L. (1999) · PubMed · Cited by 284
Kadowaki, N., Antonenko, S., & Liu, Y.-J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2291 · Cited by 280
IFN‐α/β enhances BCR‐dependent B cell responses
Braun, D., Caramalho, I., & Demengeot, J. (2002) · International Immunology · doi:10.1093/intimm/14.4.411 · Cited by 268
Vallin, H., Perers, A., Alm, G. V., & Rönnblom, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6306 · Cited by 256
Gürsel, M., Verthelyi, D., Gürsel, I., Ishii, K. J., & Klinman, D. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.5.813 · Cited by 214
Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA.
Yi, A., & KRIEG, A. M. (1998) · PubMed · Cited by 208
CpG DNA and LPS induce distinct patterns of activation in human monocytes
Hartmann, G., & Krieg, A. M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300880 · Cited by 208
Self-citationCutting Edge: Rapid Induction of Mitogen-Activated Protein Kinases by Immune Stimulatory CpG DNA
Yi, A.-K., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4493 · Cited by 175
Plasmacytoid dendritic cells: the key to CpG
Rothenfusser, S., Tuma, E., Endres, S., & Hartmann, G. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00749-8 · Cited by 164
Self-citationCausing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA
Krieg, A. Μ., & Wagner, H. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01719-9 · Cited by 132
Mechanism of Action of CpG DNA
KRIEG, A. M., Hartmann, G., & Yi, A. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59672-8_1 · Cited by 116
Self-citationThe natural interferon-α producing cells in systemic lupus erythematosus
Rönnblom, L., & Alm, G. V. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00757-7 · Cited by 112
Båve, U., Vallin, H., Alm, G. V., & Rönnblom, L. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2001.0519 · Cited by 104
Distinct CpG oligonucleotide sequences activate human γ δ T cells via interferon-α/-β
Rothenfußer, S., Hornung, V., Krug, A., Towarowski, A., Krieg, A. Μ., Endres, S., & Hartmann, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200112)31:12<3525::aid-immu3525>3.0.co;2-5 · Cited by 87
Self-citationMagnusson, M., Magnusson, S., Vallin, H., Rönnblom, L., & Alm, G. V. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.01018.x · Cited by 74
Hartmann, G., Krug, A., Bidlingmaier, M., Hacker, U. T., Eigler, A., Albrecht, R., Strasburger, C. J., & Endres, S. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37460-9 · Cited by 59
Self-citation
Cited by
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
Immunotherapeutic uses of CpG oligodeoxynucleotides
Klinman, D. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1329 · Cited by 1,012
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.174 · Cited by 891
Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell Function
Peng, G., Guo, Z., Kiniwa, Y., Voo, K. S., Peng, W., Fu, T., Wang, D. Y., Li, Y., Wang, H. Y., & Wang, R.-F. (2005) · Science · doi:10.1126/science.1113401 · Cited by 746
Metadata
- Authors
- Hartmann, G., Battiany, J., Poeck, H., Wagner, M., Kerkmann, M., Lubenow, N., Rothenfusser, S., & Endres, S.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2003-05-19
- Volume
- 33
- Issue
- 6
- Pages
- 1633-1641
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2058649253
- Cited by
- 296
- References
- 34
- FWCI
- 10.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.